Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$127 Mln
Revenue (TTM)
$55 Mln
Net Profit (TTM)
$0 Mln
ROE
-0 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
7.7
Industry P/E
--
EV/EBITDA
116.7
Div. Yield
0 %
Debt to Equity
0.1
Book Value
$1
EPS
$0.2
Face value
--
Shares outstanding
14,114,334
CFO
$47.23 Mln
EBITDA
$32.92 Mln
Net Profit
$-14.54 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
The Joint (JYNT)
| -1.4 | -2.3 | -1.4 | -29.3 | -20.1 | -28.4 | 9.8 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
The Joint (JYNT)
| -18.0 | 10.5 | -31.3 | -78.7 | 150.2 | 62.7 | 94.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
The Joint (JYNT)
|
8.6 | 127.1 | 54.9 | 2.9 | -1.1 | 16.3 | -- | 7.7 |
| 14.0 | 3,186.8 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 380.6 | 5,278.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 20.1 | 5.3 | |
| 54.5 | 2,778.6 | 941.5 | 105.7 | 14.5 | 29.4 | 26.2 | 7.3 | |
| 97.4 | 9,812.1 | 5,935.2 | 566.2 | 18.1 | 25.1 | 17.6 | 3.9 | |
| 19.1 | 4,280.7 | 2,347.6 | 128.4 | 4.5 | 25.2 | 36.8 | 7.9 | |
| 27.5 | 4,285.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.3 | 3.3 | |
| 54.8 | 4,326.1 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.0 | |
| 15.0 | 3,768.2 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.1 | 6.2 | |
| 196.6 | 11,646.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 34.4 | 5.2 |
The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selection, construction/vendor... management and ongoing operations support. It operates through a network of franchised clinics, offering routine and affordable chiropractic adjustments using a private pay, non-insurance, cash-based model. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona. Address: 16767 North Perimeter Drive, Scottsdale, AZ, United States, 85260 Read more
CEO, President & Director
Mr. Peter D. Holt
CEO, President & Director
Mr. Peter D. Holt
Headquarters
Scottsdale, AZ
Website
The share price of The Joint Corp (JYNT) is $8.60 (NASDAQ) as of 02-Apr-2026 16:00 EDT. The Joint Corp (JYNT) has given a return of -20.05% in the last 3 years.
Since, TTM earnings of The Joint Corp (JYNT) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
43.73
|
8.45
|
|
2024
|
-27.44
|
7.70
|
|
2023
|
-14.54
|
5.73
|
|
2022
|
330.54
|
6.36
|
|
2021
|
129.79
|
32.42
|
The 52-week high and low of The Joint Corp (JYNT) are Rs 13.47 and Rs 7.50 as of 03-Apr-2026.
The Joint Corp (JYNT) has a market capitalisation of $ 127 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in The Joint Corp (JYNT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.